Alexandria Real Estate Equities, Inc. Reports 3Q26 and YTD 3Q26 Net Loss per Share - Diluted of $3.74 and $2.06, respectively, and 3Q26 and YTD 3Q26 FFO per Share - Diluted, as Adjusted, of $1.54 and $5.00, respectively

Alexandria Real Estate Equities (ARE) reported 3Q26 net loss per share of $3.74 and YTD loss of $2.06. FFO per share was $1.54 for 3Q26 and $5.00 YTD. The company has $21.01B market cap, $8.11B equity, and $4.56B liquidity. 3Q26 leasing volume exceeded 1.2M RSF, highest since 4Q24. Occupancy was 88.1% in 3Q26, down from 91.7% YoY. ARE sold a 29% interest in Campus Point for $475M and plans to sell 421 Park Drive, reducing future construction spend by $136M.

Original reporting
Published Oct 26, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Alexandria Real Estate Equities, Inc. Reports 3Q26 and YTD 3Q26 Net Loss per Share - Diluted of $3.74 and $2.06, respectively, and 3Q26 and YTD 3Q26 FFO per Share - Diluted, as Adjusted, of $1.54 and $5.00, respectively — source image
Decision brief

The 30-second read

$AREBearishHigh
01

Why it matters

The earnings miss and higher leverage could trigger short‑term price declines, but strong leasing activity may support longer‑term fundamentals.

02

Market read

Primary earnings disclosure for a $21B REIT; material for REIT and office‑space investors.

03

What to watch

Strong leasing volume and liquidity cushion may mitigate concerns about the loss.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Alexandria Real Estate Equities, a specialty REIT focused on life‑science campuses, released its Q3 2026 financials.

Company-level read

Ticker impact

$AREBearishHigh confidence
Context

Q3 2026 earnings release showing net loss per share and leverage metrics.

Expected impact

likely downward pressure as investors digest the loss and higher leverage.

Evidence & confidence

Earnings surprise with negative earnings and leverage increase typically triggers sell‑offs in REITs.

Market effects

May prompt re‑rating of other high‑leverage REITs and affect the broader office‑space REIT sector.

Limited to U.S. REIT market; no broader regional effect.

Low global impact beyond REIT investors.

Counterpoint

If the loss is viewed as a one‑off due to non‑recurring items, the stock could be undervalued.

Key entities

  • Alexandria Real Estate Equities, Inc.

    Specialty REIT reporting Q3 2026 results.

Related articles

$AREHigh

BofA downgrades Alexandria Real Estate stock rating on earnings concerns

BofA Securities downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $45 from $55. The company reported a $8.40 per share loss and 9.77% revenue decline over the last year, despite a 6.5% dividend yield. BofA cited declining earnings and leasing challenges as reasons for the downgrade. Alexandria's Q3 2026 results showed mixed performance, with revenue exceeding estimates but significant earnings loss due to real estate impairments.

$AREMedAI 8/10

Alexandria Real Estate Equities Inc (ARE) (Q3 2026) Earnings Call Highlights: Record

Alexandria Real Estate Equities Inc (ARE) reported Q3 2026 earnings with record leasing of 1.2M sq ft, strong liquidity at $4.6B, and $1.7B in capital raised. However, same-property NOI declined 6.7% (GAAP) due to lower occupancy (87.1%). The company expects temporary occupancy pressure in early 2027 and recognized $638M in impairments. Management discussed development spending, tenant wind-downs, and disposition strategies during the earnings call.

$AREHighAI 8/10

KKR Makes $475M Bet in San Diego's Life Science Market

KKR invested $475M in Alexandria Real Estate Equities' 2M sq ft San Diego life science campus, taking a 49% stake. The joint venture will support leasing and development. Alexandria's CEO called it a step to optimize capital. Tenants include Bristol Myers Squibb and Eli Lilly. KKR has invested $20B in life sciences since 2004.

$AREHighAI 8/10

KKR Acquires 49% Stake in Alexandria Real Estate Equities' Campu

KKR & Co. acquired a 49% stake in Alexandria Real Estate Equities Inc.'s (ARE) Campus Point life science Megacampus for $475 million. ARE retains majority ownership and management control. The company's P/S ratio is 2.35, below its historical median, and it has a GF Score of 61/100, indicating moderate fundamental health with weaknesses in financial strength and valuation.

$AREMedAI 8/10

KKR invests $475m in Alexandria Real Estate Equities’ Campus Point

KKR invested $475m in Alexandria Real Estate Equities' Campus Point, a 2M sq. ft. life sciences campus in San Diego. KKR holds a 49% stake, while Alexandria retains majority ownership. The deal provides Alexandria with capital for development and leasing. Campus Point is home to companies like Novartis.